News
Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024
-
HONG KONG , March 28, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced its unaudited financial results for the six months ended September 30, 2024. Financial Highlights for the Six Months Ended September 30, 2024: Net Revenues: The Company reported net revenues of $11, 091,189, an increase of 58.9% compared to $7,009,209 for the same period in 2023.03/28/2025
U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline
-
Three IPOs and three SPACs were listed this week. Eight issuers submitted initial filings this week, including a handful of sizable names. The US IPO market is set to host a historic event in the week ahead.01/18/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions
Is Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) a buy, sell, or hold?
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) can sell. Click on Rating Page for detail.
What is Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's stock price?
The price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is 1.36 and it was updated on 2025-10-02 13:00:23.
Is Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) overvalued or undervalued?
Currently Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is in overvalued.
News
| News |
|---|
 Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
|
SEC Filings
Press Releases
| StockPrice Release |
|---|
HKPD Ratings Summary
HKPD Quant Ranking
